Pharmaceutical drugs are contaminants of emerging concern and are amongst the most frequent in the aquatic environment. Even though a vast literature indicate that pharmaceuticals exert negative impacts towards aquatic organisms, mainly in vertebrates, there is still limited information regarding the effects of these drugs in freshwater and marine bivalves. Marine bivalves have a high ecological and socio-economic value and are considered good bioindicator species in ecotoxicology and risk assessment programs. Furthermore, another lacking point on these studies is the absence of bioconcentration data, with no clear relationship between the concentration of drugs on tissue and the biological effects. 17alpha-ethinylestradiol (EE2) is a synthetic hormone with high estrogenic potency that was added to the Watch List adopted by the European Commission stating the priority substances to be monitored. Thus, this review summarizes the current knowledge on the concentration levels and effects of EE2 on freshwater and marine bivalves. The inclusion in the Watch List, the presence in freshwater and marine systems, and the impact exerted on aquatic biota, even at trace concentrations, justify the review devoted to this pharmaceutical drug. Globally the available studies found that EE2 induces individual and sub-individual (e.g. tissue, cellular, biochemical and molecular levels of biological organization) impacts in bivalves. Essentially, this estrogenic compound, even in trace concentrations, was found to have accumulated in wild and laboratory exposed bivalves. The most common effects reported were changes on the reproductive function and energy metabolism. The studies used in this review support keeping the EE2 on the Watch List and highlight the need to increase the number of monitorization studies since clear negative effects were exerted on bivalves by this drug.
Keywords: Accumulation; EE2; Estrogenic compounds; Invertebrates; Toxicity.
Copyright © 2020. Published by Elsevier Inc.